Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Psychemedics

NASDAQ PMD
$2.57 -0.08 -3.11%
Today share price
USA
Sector: Healthcare Industry: Health Care Providers & Services
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 29 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

14.92M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
14.31M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.74
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
5.81M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-13.17 %

Upcoming events Psychemedics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Psychemedics

Stock analysis Psychemedics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-3.59 15.68
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
2.24 2.61
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-57.24 12.57
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
2.44 1.09
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-62.26 3.65

Price change Psychemedics per year

3.58$ 8.60$
Min Max

Summary analysis Psychemedics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Psychemedics

Revenue and net income Psychemedics

All parameters

Stock news Psychemedics

All news
12 August 2023 в 01:10

Psychemedics 2Q Loss Widens Amid Labor Shortage, Settlement

12 August 2023 в 01:10

Psychemedics 2Q Loss Widens Amid Labor Shortage, Settlement

12 August 2023 в 01:00

Psychemedics Eliminates Dividend

12 August 2023 в 00:55

Psychemedics Eliminates Dividend

13 July 2023 в 00:40

Psychemedics Taps Brian Hullinger as Successor of Long-Time CEO Ray Kubacki

13 July 2023 в 00:35

Psychemedics Taps Brian Hullinger as Successor of Long-Time CEO Ray Kubacki

About company Psychemedics

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.
Address:
289 Great Road, Acton, MA, United States, 01720
Company name: Psychemedics
Issuer ticker: PMD
ISIN: US7443752057
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 1994-02-17
Sector: Healthcare
Industry: Health Care Providers & Services
Site: https://www.psychemedics.com

On which stock exchange are Psychemedics (PMD) stocks traded?

Psychemedics (PMD) stocks are traded on NASDAQ.

What is the ticker of Psychemedics stocks (PMD)?

The stock ticker of Psychemedics’s stocks or in other words, the code is PMD. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Psychemedics (PMD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Psychemedics (PMD) belongs to the «Healthcare» sector and the «Health Care Providers & Services» industry.

In what currency are Psychemedics (PMD) stocks traded?

Psychemedics (PMD) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Psychemedics (PMD) stocks today?

The current price of Psychemedics stocks on 16.05.2024 is 2.5701 dollars. per share.

What is the dynamics of Psychemedics (PMD) stocks from the beginning of the year?

Psychemedics (PMD) quotes have increased by -24.19% from the beginning of the year up to 2.5701 dollars. per 1 stocks.

How much did Psychemedics (PMD) stocks increase in мае 2024?

This month Psychemedics (PMD) quotes have increased by -1.9% to 2.5701 dollars. per share.

How much are Psychemedics (PMD) stocks worth?

Today, on October, 16.05.2024 Psychemedics’s (PMD) stocks cost 2.5701 dollars..

What is the market capitalization of Psychemedics (PMD)?

Capitalization is the market value of Psychemedics (PMD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Psychemedics (PMD) is estimated at about 14922001 dollars.